Tato stránka byla automaticky přeložena a přesnost překladu není zaručena. Podívejte se prosím na anglická verze pro zdrojový text.

Addressing Food Insecurity in Pregnancy

3. listopadu 2026 aktualizováno: Women and Infants Hospital of Rhode Island

The goal of this observational study is to learn if providing meal kits during pregnancy is helpful for people experiencing food insecurity. The study will also learn about participants' experiences with receiving meal kits during pregnancy and after giving birth. The main questions it aims to answer are:

  • Does receiving meal kits affect pregnancy and health outcomes?
  • How do participants experience and use the meal kits?
  • What benefits or challenges do participants report when receiving the meal kits?

Participants who screen positive for food insecurity during routine prenatal care will be offered weekly meal kits through Meals on Wheels Rhode Island (MoWRI). Participants who accept the meal program will receive meal kits throughout pregnancy and through two weeks after giving birth. Participants who do not enroll in the meal program will continue to receive their usual prenatal care and referrals to food and nutrition resources.

Participants will:

  • Complete surveys about their health, food access, and experiences with the meal program.
  • Continue their regular prenatal care.
  • Some participants will be invited to complete an interview about their experiences.

Přehled studie

Postavení

Zatím nenabíráme

Detailní popis

Food insecurity during pregnancy is associated with adverse maternal and perinatal outcomes and may be an important modifiable social determinant of health. This mixed-methods observational study will evaluate the feasibility, acceptability, and preliminary outcomes associated with providing meal support to pregnant persons experiencing food insecurity who receive prenatal care at the Women & Infants Hospital of Rhode Island Obstetrics and Gynecology Care Center (OGCC).

All pregnant persons receiving prenatal care at the OGCC are routinely screened for food insecurity as part of social determinants of health screening. Screening may be conducted using the clinic's standard screening language or the Hunger Vital Sign, a validated two-question screening tool derived from the U.S. Household Food Security Survey Module.

  1. "Within the past 12 months we worried whether our food would run out before we got money to buy more."
  2. "Within the past 12 months the food we bought just didn't last and we didn't have money to get more."

A response of "sometimes true" or "often true" to either or both questions is considered a positive screen for food insecurity.

Individuals who screen positive for food insecurity during a routine prenatal visit, including prenatal intake, new obstetric visits, new high-risk appointments, or other obstetric follow-up visits, will be offered enrollment in Meals on Wheels Rhode Island (MoWRI). Participants who agree to participate in the meal delivery program will comprise the intervention group. Their contact information will be provided to MoWRI, which will confirm individual and/or household meal needs and arrange delivery of weekly meal kits throughout pregnancy through two weeks postpartum.

Participants who decline or do not enroll in the MoWRI meal program for any reason will comprise the usual-care group. These participants will continue to receive standard prenatal care, including routine nutrition counseling and referrals to community resources such as the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC), Supplemental Nutrition Assistance Program (SNAP), and other resources available through the OGCC.

Assignment to the intervention or usual-care group will not be randomized. Group assignment will be determined by the participant's decision to accept or decline enrollment in the MoWRI meal program. Participants in both groups will otherwise receive the same routine prenatal medical care, with medical problems documented and managed according to standard clinical practice.

A mixed-methods approach will be used to evaluate participant outcomes and experiences. Quantitative data will be collected through participant surveys and abstraction of relevant information from the medical record. Qualitative data will be collected through participant interviews exploring experiences with food insecurity, the meal program, prenatal care, and perceived benefits or challenges associated with the intervention. Quantitative and qualitative findings will be analyzed in parallel and integrated to provide a comprehensive assessment of the intervention and participant experiences.

Typ studie

Pozorovací

Zápis (Odhadovaný)

700

Kontakty a umístění

Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.

Studijní kontakt

Studijní záloha kontaktů

Kritéria účasti

Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.

Kritéria způsobilosti

Věk způsobilý ke studiu

18 let až 50 let (Dospělý)

Přijímá zdravé dobrovolníky

Ne

Pohlaví způsobilá ke studiu

Ženský

Metoda odběru vzorků

Vzorek nepravděpodobnosti

Studijní populace

All pregnant persons receiving prenatal care at the OGCC are screened for food insecurity using either the clinic's standard verbiage during the routine social determinants of health screening or the "Hunger Vital Sign" during their routine prenatal visits (including their prenatal intake visit, new OB visit, new High-Risk appointments, or other OB follow up visits). Those who screen positive during one of these visits will be offered enrollment into MoWRI's supplemental nutrition program and this study. Patient who choose to receive meals through MoWRI can opt out of participation in the study. Patients who elect not to receive meals through MoWRI are still eligible to participate in the study.

Popis

Inclusion Criteria:

  • Pregnant persons aged 18-50 years.
  • Receiving prenatal care at the Women & Infants Hospital of Rhode Island (WIH) Obstetrics & Gynecology Care Center (OGCC).
  • Screen positive for food insecurity.
  • Able to give informed consent (interpreter services will be offered for non-English speakers).
  • Planning to continue care and deliver at WIH.

Exclusion Criteria:

  • Plans to relocate or transfer prenatal care outside OGCC before delivery.
  • Medical contraindications that would severely alter dietary intake (as assessed by clinician).

Studijní plán

Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.

Jak je studie koncipována?

Detaily designu

  • Observační modely: COHORT
  • Časové perspektivy: PROSPECTIVE

Kohorty a intervence

Skupina / kohorta
Intervence / Léčba
Usual Care

Participants identified as food insecure and referred to Social Work for standard assistance.

Intervention with Meal Supplementation

Participants identified as food insecure and referred to meal supplementation program, based on program availability.

Weekly deliveries of supplemental meals to pregnant persons and their households from enrollment until two weeks postpartum.

Co je měření studie?

Primární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Qualitative perceptions of nutritional support and dietary quality among program participants
Časové okno: Within 12 months following completion of the nutritional intervention

Assessment of pregnant patients' experiences, program satisfaction, barriers to food access, and perceived changes in dietary quality resulting from the Meals on Wheels Rhode Island program. Data will be collected via semi-structured qualitative interviews or focus groups with the intervention group. Eligible participants include those who completed the nutritional intervention prior to the interview date. Text data will be transcribed and analyzed using thematic analysis.

Within 12 months following completion of the nutritional intervention
Proportion of participants experiencing any maternal medical complication
Časové okno: From enrollment through delivery (up to 42 weeks of gestation)

A composite clinical endpoint evaluating overall maternal health complications. A participant will be counted once if they develop at least one of the following clinically diagnosed conditions: gestational diabetes, anemia, chronic hypertension, pulmonary hypertension, gestational hypertension, preeclampsia, or eclampsia. Rates will be compared between the intervention group (receiving meal delivery) and the control group (not receiving meals).

From enrollment through delivery (up to 42 weeks of gestation)

Sekundární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Proportion of participants experiencing delivery-related complications
Časové okno: At delivery (up to 42 weeks of gestation)

The percentage of participants who experience at least one of the following binary (yes/no) labor and delivery events: mode of delivery categorized as cesarean section (vs. vaginal delivery), placental complications (e.g., abruption or previa), clinically documented maternal infections during labor, precipitous labor and delivery (expulsion of the fetus within 3 hours of regular contractions), or an umbilical cord complication.

At delivery (up to 42 weeks of gestation)
Gestational age at delivery
Časové okno: At delivery (up to 42 weeks of gestation)

Gestational age at delivery, measured in completed days.

At delivery (up to 42 weeks of gestation)
Proportion of neonates with breech or fetal malpresentation
Časové okno: At delivery (up to 42 weeks of gestation)

The percentage of neonates presenting in a breech position or other non-vertex fetal malpresentation (yes/no) documented by the clinical team at the time of delivery.

At delivery (up to 42 weeks of gestation)
Change from baseline in maternal depression symptoms
Časové okno: Baseline (Prenatal Intake or New OB visit, whichever comes first) to approximately 6 weeks postpartum

This outcome tracks maternal mental health metrics over time, comparing the intervention group to the control group. It measures depression symptoms using the Patient Health Questionnaire-9 (PHQ-9) total score (range 0-27, higher scores indicate worse symptoms).

Baseline (Prenatal Intake or New OB visit, whichever comes first) to approximately 6 weeks postpartum
Neonate birth weight
Časové okno: At birth (up to 42 weeks of gestation)

Neonate birth weight, measured continuously in grams.

At birth (up to 42 weeks of gestation)
Apgar scores
Časové okno: 1, 5, and 10 minutes after birth

Apgar scores assessed at 1, 5, and 10 minutes after birth. Each score is measured on a standardized scale from 0 to 10, with higher scores indicating better clinical transition.

1, 5, and 10 minutes after birth
Change in maternal weight from baseline
Časové okno: Baseline (Prenatal Intake or New OB visit, whichever comes first) to approximately 6 weeks postpartum

This outcome tracks maternal gestational weight gain (measured in kilograms) over time, comparing the intervention group to the control group.

Baseline (Prenatal Intake or New OB visit, whichever comes first) to approximately 6 weeks postpartum
Proportion of participants with a preterm delivery
Časové okno: At delivery (up to 42 weeks of gestation)

The percentage of participants who experience a live birth prior to 37 completed weeks of gestation (less than 259 days). Gestational age will be determined based on the first day of the last menstrual period and confirmed by early ultrasound dating. Rates will be compared between the intervention group (receiving MoWRI meal delivery) and the concurrent control group (not receiving meals).

At delivery (up to 42 weeks of gestation)

Spolupracovníci a vyšetřovatelé

Zde najdete lidi a organizace zapojené do této studie.

Vyšetřovatelé

  • Vrchní vyšetřovatel: Janet Lefkowitz, DO, Women & Infants Hospital

Publikace a užitečné odkazy

Osoba odpovědná za zadávání informací o studiu tyto publikace poskytuje dobrovolně. Mohou se týkat čehokoli, co souvisí se studiem.

Obecné publikace

Termíny studijních záznamů

Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.

Hlavní termíny studia

Začátek studia (Odhadovaný)

1. listopadu 2026

Primární dokončení (Odhadovaný)

1. ledna 2029

Dokončení studie (Odhadovaný)

1. ledna 2029

Termíny zápisu do studia

První předloženo

19. srpna 2026

První předloženo, které splnilo kritéria kontroly kvality

3. listopadu 2026

První zveřejněno (Aktuální)

5. listopadu 2026

Aktualizace studijních záznamů

Poslední zveřejněná aktualizace (Aktuální)

5. listopadu 2026

Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality

3. listopadu 2026

Naposledy ověřeno

1. srpna 2026

Více informací

Termíny související s touto studií

Další identifikační čísla studie

  • WIH-1921808

Plán pro data jednotlivých účastníků (IPD)

Plánujete sdílet data jednotlivých účastníků (IPD)?

NE

Popis plánu IPD

Individual participant data will not be shared with researchers outside of the study team. Study data will include information obtained from medical records, participant-completed surveys, and qualitative interviews, including demographic, clinical, pregnancy, delivery, neonatal, and survey data. Interview transcripts will contain participants' open-ended responses to semi-structured interview questions. Data will be stored securely and access will be limited to authorized members of the research team. Because the study collects sensitive health and personal information, IPD will not be made available for sharing outside the institution. Any future data sharing or transfer outside the institution would require appropriate institutional and IRB approval and applicable data-sharing agreements and privacy protections.

Informace o lécích a zařízeních, studijní dokumenty

Studuje lékový produkt regulovaný americkým FDA

Ne

Studuje produkt zařízení regulovaný americkým úřadem FDA

Ne

Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .

Předplatit